Statistics for Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
Total visits
| views | |
|---|---|
| Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period | 0 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |